In this response I discuss Shabad and Gerson’s viewpoints, not only in relation to my own but also to each other, in an effort to delineate variables at play within analytic subjectivity when we are confronted by issues concerning mortality in treatment. I suggest that our personal relationships with our own mortality, in conjunction with our analytic commitments and clinical sensibilities, determine how we will talk with patients about their having to die and/or if we will talk with them about it at all.